Free Newsletter
Acambis launches C. diff trial; VaxInnate takes second flu vaccine to clinic;
Vaccine Research
Acambis has begun a large human trial of an experimental vaccine for the superbug C. difficile. Report
VaxInnate announced that its second influenza vaccine candidate has entered clinical development. VaxInnate release
Researchers at Wayne State University say that a preclinical breast cancer vaccine destroyed HER2-positive tumors without toxicity. Story
A French study has concluded that children with MS were almost twice as likely to have been given the Engerix B vaccine for hepatitis B. New work is being done to see if the vaccine triggers MS. Report
Vaccine Market
Citing the worsening economic climate, Solvay Pharmaceuticals says it won't be building a new, $386 million flu vaccine manufacturing facility. Report
Antigenics has won permission to start exporting its cancer vaccine to Russia. Antigenics release
Some advocacy groups are challenging a new rule that requires female immigrants aged 11 to 26 to get an HPV vaccination. Report
Comments
Post new comment
Paid Research Reports
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
- Innovative Drug Discovery in Emerging Markets
- Market Opportunities for Supergenerics
- The Future of In Vitro and In Vivo Diagnostic Integration
SHARE
WITH: